Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticotropin releasing factor (CRF): diagnostic implications.

O A Müller, G K Stalla, J Hartwimmer

    Acta Neurochirurgica
    |January 1, 1985
    PubMed
    Summary

    Ovine Corticotropin Releasing Factor (oCRF) administration is a safe and effective tool for diagnosing hypothalamo-pituitary-adrenal axis disorders. The CRF test aids in differentiating causes of hyper- and hypofunction, offering prognostic value post-treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oxytocin and cortisol concentrations in adults with and without autism spectrum disorder in response to physical exercise.

    Comprehensive psychoneuroendocrinology·2022
    Same author

    Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study.

    Journal of endocrinological investigation·2020
    Same author

    Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry.

    European journal of endocrinology·2020
    Same author

    [Substitution with thyroid hormones in the elderly : Goals and risks].

    Der Internist·2018
    Same author

    Protein stabilization by RSUME accounts for PTTG pituitary tumor abundance and oncogenicity.

    Endocrine-related cancer·2018
    Same author

    Longitudinal change instead of baseline testosterone predicts depressive symptoms.

    Psychoneuroendocrinology·2018

    Area of Science:

    • Endocrinology
    • Neuroendocrinology
    • Hormone Research

    Background:

    • The hypothalamo-pituitary-adrenal (HPA) axis regulates stress response and cortisol production.
    • Corticotropin-Releasing Factor (CRF) is a key regulator of the HPA axis, synthesized in the hypothalamus.
    • Disorders of the HPA axis, such as Cushing's syndrome and adrenal insufficiency, require accurate diagnostic tools.

    Purpose of the Study:

    • To evaluate the safety and efficacy of ovine Corticotropin Releasing Factor (oCRF) in stimulating adrenocorticotropic hormone (ACTH), beta-endorphin, and cortisol secretion.
    • To assess the dose-response relationship of oCRF and its correlation with measured CRF immunoreactivity.
    • To determine the utility of the CRF test in the differential diagnosis and prognosis of HPA axis disorders.

    Main Methods:

    Related Experiment Videos

    • Intravenous bolus injection of varying doses of oCRF (50, 100, 200 micrograms) in normal volunteers.
    • Administration of synthetic human CRF (50 and 100 micrograms) for comparison.
    • Measurement of ACTH, beta-endorphin, cortisol, and CRF immunoreactivity using radioimmunoassay.
    • Clinical application of the CRF test in patients with Cushing's syndrome and other HPA axis diseases.

    Main Results:

    • No significant dose-response relationship was observed between injected oCRF and stimulated ACTH, beta-endorphin, or cortisol secretion.
    • A clear dose-response relationship was found between injected oCRF and measured CRF immunoreactivity.
    • The CRF test proved useful in differentiating ACTH-dependent Cushing's disease, adrenal tumors, and ectopic ACTH syndrome.
    • The test showed prognostic value after surgery for Cushing's syndrome and helped document secondary adrenal failure.
    • Corticoid therapy was found to suppress CRF-induced ACTH secretion, primarily at the pituitary level.

    Conclusions:

    • Ovine CRF administration is a well-tolerated and valuable diagnostic tool for HPA axis hyper- and hypofunction.
    • The CRF test aids in differential diagnosis, distinguishing between hypothalamic and pituitary causes of ACTH hyposecretion.
    • Preliminary findings suggest endogenous CRF levels correlate with clinical status and ACTH levels, warranting further investigation with homologous assays.